Aducanumab is the first disease-modifying treatment to be approved for Alzheimer's Disease (AD) and the first to target amyloid ß (Aß), which is one of the earliest causative steps in the pathophysiology of AD.

The Food and Drug Administration on June 7 approved Aducanumab, which will carry the brand name Aduhelm, as the first new treatment for Alzheimer’s disease in nearly 20 years.

After closing the books on its first year of legalized sports betting, Colorado collected more than $6.6 million in tax revenue. The programs set to receive that money will start to do so this fall.

The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc’s aducanumab, a decision that will affect the future of Alzheimer’s disease research and treatment and show the agency’s willingness to approve badly needed medicines based on less than definitive data.

A rapidly recovering Las Vegas will be the focus of the global tourism industry Monday, when World of Concrete stages the first major trade show in the United States since the COVID pandemic wiped out the lucrative convention and meeting business.

Rush Street Gaming is increasing its hourly salary to $15 for non-tipped workers at Rivers Casinos. The rise comes as many gaming properties nationally apparently face a worker shortage with casinos resuming operations following COVID-19 closings.

When Michelle Mihalik was hit by a car on March 8, 2018, she didn’t see it coming.

The National Association of Home Builders has said that lumber prices are triple what they were in April 2020, increasing average single-family home construction by nearly $36,000.

Colgate-Palmolive (Colgate) has sent the first-ever private sector oral care experiment to the International Space Station (ISS), under the sponsorship of the ISS U.S. National Laboratory (National Lab).